Peripheral differential leukocyte counts and subsequent mortality from all diseases, cancers, and cardiovascular diseases in Taiwanese

Journal of the Formosan Medical Association

Volumn 102, Issue 11, 2003, Pages 775-781

  Huang, Zei Shung ^a   Chien, Kuo Liong ^a   Yang, Chi Yu ^a   Wang, Chiu Hwa ^a   Chang, Tien Chun ^a   Chen, Chien Jen ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cardiovascular diseases; Leukocyte count; Lymphocytes; Monocytes; Mortality; Neoplasms; Neutrophils

Indexed keywords

ADULT; AGED; ARTICLE; CANCER; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; PHYSICAL EXAMINATION; PREDICTION; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; STUDENT T TEST; TAIWAN; UNIVERSITY HOSPITAL; ADOLESCENT; LEUKOCYTE COUNT; MIDDLE AGED; MORTALITY; NEOPLASM; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; HUMANS; LEUKOCYTE COUNT; MIDDLE AGED; MORTALITY; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TAIWAN;

EID: 1342285091     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Weijenberg MP, Feskens EJ, Kromhout D: White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 1996;16:499-503.
2. Gillum RF, Ingram DD, Makuc DM: White blood cell count, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1993;125:855-63.
3. de Labry LO, Campion EW, Glynn RJ, et al: White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. J Clin Epidemiol 1990;43:153-7.
4. Grimm RH Jr, Neaton JD, Ludwig W: Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 1985;254:1932-7.
5. Kannel WB, Anderson K, Wilson PWF: White blood cell count and cardiovascular disease: insights from the Framingham study. JAMA 1992;267:1253-6.
6. Yarnell JWG, Baker IA, Sweetnam PM, et al: Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991;83:836-44.
7. Friedman GD, Tekawa I, Grimm RH, et al: The leukocyte count: correlates and relationship to coronary risk factors (the CARDIA study). Int J Epidemiol 1990;19:889-93.
8. Nieto FJ, Szklo M, Folsom AR, et al: Leukocyte count correlates in middle-aged adults: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 1992;136:525-37.
9. Belch JJF: The relationship between white blood cells and arterial disease. Curr Opin Lipidol 1994;5:440-6.
10. Prentice RL, Szatrowski TP, Kato H, et al: Leukocyte counts and cerebrovascular disease. J Chronic Dis 1982;35:703-14.
11. Huang ZS, Jeng JS, Wang CH, et al: Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis 2001;158:431-6.
12. Fiala J, Brazdova Z: A comparison between the lifestyles of men and women - parents of school age children. Cent Eur J Public Health 2000;8:94-100.
13. Bender BS, Nagel JE, Adler WH, et al: Absolute peripheral blood lymphocyte count and subsequent mortality of elderly men. The Baltimore longitudinal study of aging. J Am Geriatr Soc 1986;34:649-54.
14. Hickey WF: Basic principles of immunological surveillance of the normal central nervous system. Glia 2001;36:118-24.
15. Pinkoski MJ, Green DR: Cloak and dagger in the avoidance of immune surveillance. Curr Opin Genet Dev 2000;10:114-9.
16. Crowe NY, Smyth MJ, Godfrey DI: A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J Exp Med 2002;196:119-27.
17. Braun DP, Harris JE: Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients. J Natl Cancer Inst 1981;67:809-14.
18. Yu MW, Hsu FC, Sheen IS, et al: Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997;145:1039-47.
19. Hsu HC, Wu MZ, Chang MH, et al: Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis. J Hepatol 1987;5:260-7.
20. Ward PC: The myeloid leukocytoses. Postgrad Med 1980;67:219-21, 224-6, 229.
21. Noguchi T, Tsujisaki M, Imai K, et al: Relationship among risk factors of atherosclerosis, leukocyte count, and soluble intercellular adhesion molecule-1. Intern Med 1998;37:123-6.
22. Ross R: Cell biology of atherosclerosis. Annu Rev Physiol 1995;57:791-804.
23. Joris I, Zand T, Nunnari JJ, et al: Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am J Pathol 1983;113:341-58.
24. Blann AD, Seigneur M, Adams RA, et al: Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis. Eur J Vasc Endovasc Surg 1996;12:218-22.
25. Mohacsi A, Fulop T Jr, Kozlovszky B, et al: Sera and leukocyte elastase-type protease and antiprotease activity in healthy and atherosclerotic subjects of various ages. J Gerontol 1992;47:B154-8.